View at Publisher | View at Google Scholar Wang Y et al
Dose escalation should not occur during acute illness, periods of poor oral intake, or when gastrointestinal symptoms from the current dose remain problematic
Health Canadas classification of peptides depends on intended use, marketing claims, and manufacturing standards
also authorised as Zepbound for weight management, though NHS access for weight management depends on NICE guidance and local commissioning decisions [11] [12] Referral to a Tier 3 or Tier 4 specialist weight management service for more complex cases If you are interested in participating in a clinical trial involving retatrutide or similar investigational medicines, your GP may be able to refer you to a research centre
Noom and Hims physicians screen for these during their consultation process
And here is the compounding problem: if you are also dealing with nausea or vomiting (both common early side effects of GLP-1 drugs), the resulting dehydration makes the dryness even worse